Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-09-14
1994-12-06
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 31535
Patent
active
053710827
ABSTRACT:
The invention relates to the use of p-chloro-N-(2-morpholinoethyl)benzamide in the treatment of anxiety disorders, such as, panic disorders, social phobia and obsessive compulsive disorder,
REFERENCES:
patent: 4210754 (1980-07-01), Burkard et al.
patent: 4906626 (1990-08-01), Amrein et al.
Dowson, J. H., J. Neural Transm. Suppl., vol. 23, 1987, pp. 121-138.
Bechelli et al., Curr. Med. Res. Opin., vol. 11/suppl. 1, 1989, pp. 38-52.
Da Prada, et al., J. Pharmacol. Exp. Ther., 248:400-414 (1989).
Schoerlin, et al., Acta. Psychiatr. Scan. Suppl. 82(630):108-110 (1990).
Liebowitz, et al., Journal of Clinical Psychopharmacology, 6:2 pp. 93-98 (1986).
Noyes, et al., J. Clin. Psychiatry., vol. 51, pp. 24-30 (1990).
Liebowitz, et al., Acta Psychiatr. Scand., Suppl., vol. 82(360), pp. 29-34 (1990).
Liebowitz, et al., Psychiatry Research, 22:89-90 (1987).
Amrein Roman
Versiani Marcio
Cintins Marianne M.
Gould George M.
Johnston George W.
Jordan Kimberly R.
Parise John P.
LandOfFree
Treatment of anxiety disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of anxiety disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of anxiety disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-214608